Home
Akebia Therapeutics AKBA spent $360K on lobbying in Q2 2026 · Health Issues, Medicare
Trade details
- Type
- Lobbying report
- Amount
- $360,000
- Quarter
- Q2 2026
- Client
- Akebia Therapeutics
- Reported
- 26/07/20
Down 25.0% from last quarter
What else happened in Akebia Therapeutics around then
Filed or reported within 30 days of the trade day · 05/31~07/30Akebia Therapeutics's other lobbying reports
- Akebia Therapeutics
LobbyingAkebia Therapeutics
LobbyingAkebia Therapeutics
AKBA
$60K
$60K
Reported 07/20
for Q2
- Akebia Therapeutics
LobbyingAkebia Therapeutics
LobbyingAkebia Therapeutics
AKBA
$60K
$60K
Reported 07/13
for Q2
- Akebia Therapeutics
LobbyingAkebia Therapeutics
LobbyingAkebia Therapeutics
AKBA
$480K
$480K
Reported 04/20
for Q1
- Akebia Therapeutics
LobbyingAkebia Therapeutics
LobbyingAkebia Therapeutics
AKBA
$60K
$60K
Reported 04/20
for Q1
- Akebia Therapeutics
LobbyingAkebia Therapeutics
LobbyingAkebia Therapeutics
AKBA
$45K
$45K
Reported 04/05
for Q1